Quantitative determination of tenascin as glioma marker
US5436132A · kind A · utility
2Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 1993 |
| Grant date | Jul 25, 1995 |
| Priority date | — |
| Expiry date | Oct 22, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/813
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method of determining tenascin in a cerebrospinal fluid sample by immunoassay, etc. is disclosed. The tenascin level in the cerebrospinal fluid serves as a glioma marker and thus the selective diagnosis of glioma is possible.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.